- Previous Close
4.570 - Open
4.500 - Bid 4.500 x --
- Ask 4.600 x --
- Day's Range
4.500 - 4.510 - 52 Week Range
3.120 - 6.400 - Volume
64,700 - Avg. Volume
90,698 - Market Cap (intraday)
1.89B - Beta (5Y Monthly) 0.65
- PE Ratio (TTM)
-- - EPS (TTM)
-0.370 - Earnings Date Aug 30, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
4.43
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and sale of medical devices for diabetes monitoring, treatment, and management in the People's Republic of China and internationally. The company offers Equil patch insulin pump systems; AiDEX and LinX continuous glucose monitoring systems; POCT analyzer systems; closed-loop artificial pancreas systems; blood glucose monitoring systems; Exactive Pro blood glucose, blood ketone, and uric acid monitoring system; and diabetes digital management software. It is also involved in scientific research and technical services; business services; wholesale and retail; manufacturing; and commercials. MicroTech Medical (Hangzhou) Co., Ltd. was incorporated in 2011 and is headquartered in Hangzhou, the People's Republic of China.
www.microtechmd.comRecent News: 2235.HK
View More
Performance Overview: 2235.HK
Trailing total returns as of 11/15/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2235.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2235.HK
View MoreValuation Measures
Market Cap
1.92B
Enterprise Value
5.80M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.93
Price/Book (mrq)
0.89
Enterprise Value/Revenue
0.02
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-49.14%
Return on Assets (ttm)
-5.92%
Return on Equity (ttm)
-6.85%
Revenue (ttm)
293.23M
Net Income Avi to Common (ttm)
-144.09M
Diluted EPS (ttm)
-0.370
Balance Sheet and Cash Flow
Total Cash (mrq)
1.81B
Total Debt/Equity (mrq)
1.01%
Levered Free Cash Flow (ttm)
-196.54M
Research Analysis: 2235.HK
View MoreCompany Insights: 2235.HK
2235.HK does not have Company Insights